Photos

260428-N-KT630-1086

BETHESDA, Md. (Apr. 28, 2026) Pictured: a unit of a self-administered nasal spray called INNA-051, designed to prevent and reduce symptoms of viral respiratory infections like the common cold or flu. The Naval Medical Research Command’s (NMRC) Clinical Trials Center (CTC) is preparing a study into the effectiveness of INNA-051, planned to begin in September. NMRC, headquarters of Navy Medicine Research & Development, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps, and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. (U.S. Navy photo by Sidney Hinds /Released)